OCT4 pseudogenes present in human leukemia cells

Clinical and Experimental Medicine

Volumn 12, Issue 4, 2012, Pages 207-216

  Guo, Xiaoping ^a   Tang, Yongmin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Expression; Leukemia; OCT4

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4;

ADOLESCENT; ARTICLE; CANCER STEM CELL; CHILD; CHROMOSOME 1; CHROMOSOME 8; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MALE; OCT4 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LEUKEMIA; OCTAMER TRANSCRIPTION FACTOR-3; PSEUDOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 84870424158     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0163-4     Document Type: Article

References (37)

1. Witte KE, Ahlers J, Schäfer I et al (2011) High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia. Pediatr Hematol Oncol 28:91-99
2. van Rhenen A, Feller N, Kelder A et al (2005) High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 11:6520-6527 (Pubitemid 41338990)
3. Ferrando AA, Neuberg DS, Staunton J et al (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87 (Pubitemid 41039178)
4. Yamazaki H, Wilson Xu C, Naito M et al (2011) Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia. Biochem Biophys Res Commun 409:14-21
5. Rosner MH, Vigano MA, Ozato K, Timmons PM et al (1990) A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692
6. Cheng L, Sung MT, Cossu-Rocca P et al (2007) OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211:1-9 (Pubitemid 46092024)
7. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2007) OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120:1598-1602 (Pubitemid 46355399)
8. Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255-2265 (Pubitemid 41579973)
9. Iki K, Pour PM (2006) Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model. Pancreatology 6:406-413 (Pubitemid 44329087)
10. Chen Z, Xu WR, Qian H et al (2009) Oct4, a novel marker for human gastric cancer. J Surg Oncol 9:414-419
11. Jiang Y, Jahagirdar BN, Reinhardt RL et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49 (Pubitemid 34742565)
12. Kucia M, Reca R, Campbell FR et al (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+))Oct-4+ stem cells identified in adult bone marrow. Leukemia 20:857-869
13. Pochampally RR, Smith JR, Ylostalo J et al (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a sub-population of early progenitor cells with enhanced expression of Oct-4 and other embryonic genes. Blood 103:1647-1652 (Pubitemid 38268955)
14. D'Ippolito G, Diabira S, Howard GA et al (2004) Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981 (Pubitemid 39117672)
15. Baal N, Reisinger K, Jahr H et al (2004) Expression of the transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb Haemost 92:767-775 (Pubitemid 39386703)
16. Takeda J, Seino S, Bell GI (1992) Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20:4613-4620
17. Mueller T, Luetzkendorf J, Nerger K, Schmoll HJ, Mueller LP (2009) Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci 66:495-503
18. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H (2006) POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24:2685-2691 (Pubitemid 46053006)
19. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW (2008) OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 26:3068-3074
20. Wang X, Dai J (2010) Concise review: isoforms of OCT4 Contribute to the confusing diversity in stem cell biology. Stem Cells 28:885-893
21. Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Ko?gler G (2007) Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 11:364-366 (Pubitemid 47506539)
22. Redshaw Z, Strain AJ (2010) Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J Negat Results Biomed 31:2
23. Suo G, Han J, Wang X, Zhang J et al (2005) Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 337:1047-1051 (Pubitemid 41505231)
24. Schoenhals M, Kassambara A, De Vos J et al (2009) Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun 383:157-162
25. Gaussmann A, Wenger T, Eberle I et al (2007) Combined effects of the two reciprocal t(4;11) fusion proteins MLL-AF4 and AF4-MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 26:3352-3363 (Pubitemid 46788884)
26. Cantz T, Key G, Bleidissel M, Gentile L et al (2008) Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 26:692-697
27. Wilson K, Case M, Minto L et al (2010) Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+ CD38lowCD19+ in B-lineage childhoood acute lymphoblastic leukemia. Haematologica 95:679-683
28. van Rhenen A, Moshaver B, Kelder A et al (2007) Aberrant marker expression patterns on the CD34+ CD38-stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. Leukemia 21:1700-1707 (Pubitemid 47086760)
29. van Rhenen A, van Dongen GA, Kelder A et al (2007) The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood 110:2659-2666 (Pubitemid 47523190)
30. Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872 (Pubitemid 350138099)
31. Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146
32. Eberle I, Pless B, Braun M et al (2010) Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucleic Acids Res 38:5384-5395
33. Burger AM (2009) Targeting leukemic stem cells. In: Bagley RG, Teicher BA (eds) Stem cells and cancer, Humana Press, New York, pp 263-273
34. Lu C, Hassan HT (2006) Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Leuk Res 30:296-302 (Pubitemid 43053225)
35. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737 (Pubitemid 27298715)
36. Zangrossi S, Marabese M, Broggini M et al (2007) Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25:1675-1680 (Pubitemid 47121844)
37. Wang L, O'Leary H, Fortney J et al (2007) Ph?/VE-cadherin? identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells. Blood 110:3334-3344 (Pubitemid 350106327)